Zhe-Sheng Chen
St John's University
H-index: 82
Asia-Taiwan
Top articles of Zhe-Sheng Chen
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Combating antimicrobial resistance: the silent war | Letao Bo Haidong Sun Yi-Dong Li Jonathan Zhu John ND Wurpel | 2024/2/14 | |
A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer | MedComm | Shiwen Huo Jinqi Xue Shuo Wang Huilian Shan Guanglei Chen | 2024/3 |
Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cells | Frontiers in Pharmacology | Xuan-Yu Chen Zhuo-Xun Wu Jing-Quan Wang Qiu-Xu Teng Hailin Tang | 2024/5/2 |
Cardiopulmonary progenitors facilitate cardiac repair via exosomal transfer of miR‐27b‐3p targeting the SIK1‐CREB1 axis | Cell Proliferation | Ying‐Ying Xiao Luo‐Xing Xia Wen‐Jing Jiang Jian‐Feng Qin Li‐Xin Zhao | 2024/1/7 |
ABCB1-Dependent Collateral Sensitivity of Multidrug-Resistant Colorectal Cancer Cells to the Survivin Inhibitor MX106-4C | Drug Resistance Updates | Zi-Ning Lei Najah Albadari Qiu-Xu Teng Hadiar Rahman Jing-Quan Wang | 2024/2/6 |
Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor | Drug Resistance Updates | Qiu-Xu Teng Zi-Ning Lei Jing-Quan Wang Yuqi Yang Zhuo-Xun Wu | 2024/3/1 |
RETRACTED: Ashar et al. Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and Function. Biomolecules 2022, 12, 1162 | Yunali Ashar Qiuxu Teng John ND Wurpel Zhe-Sheng Chen Sandra E Reznik | 2024/4/8 | |
Cell death in cancer chemotherapy using taxanes | Frontiers in Pharmacology | Ana P Xu Lucy B Xu Elizabeth R Smith Joshua S Fleishman Zhe-Sheng Chen | 2024/1/5 |
Characterization of the Nucleus Pulposus Progenitor Cells via Spatial Transcriptomics | Advanced Science | Yu Chen Long Zhang Xueqing Shi Jie Han Jingyu Chen | 2024/2/4 |
Targeting autophagy to counteract neuroinflammation: a novel antidepressant strategy | Hua Gan Qingyu Ma Wenzhi Hao Nating Yang Zhe-Sheng Chen | 2024/2/23 | |
Abstract LB258: ZDHHC20 is a potential target for overcoming ABCB1-mediated multidrug resisance (MDR) in cancer | Cancer Research | Ning Ji Xin Peng Yi-nan Liu Yuqi Yang Zhe-Sheng Chen | 2024/4/5 |
Artemisia argyi H. Lév. & Vaniot: a comprehensive review on traditional uses, phytochemistry, and pharmacological activities | Wen-Jun Wei Tao Guo Gui-Min Xue Rui Ma Yuefei Wang | 2024/1/31 | |
Nanotechnology-based delivery systems to overcome drug resistance in cancer | Harsh Patel Jiaxin Li Letao Bo Riddhi Mehta Charles R Ashby Jr | 2024/2/20 | |
Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke | Journal of Controlled Release | Yi Li Jun Liao Liyan Xiong Zhicheng Xiao Fei Ye | 2024/4/1 |
Therapeutic evolution in HR+/HER2-breast cancer: from targeted therapy to endocrine therapy | Lu-Qi Cao Haidong Sun Yuhao Xie Harsh Patel Letao Bo | 2024/1/24 | |
Ferroptosis as a potential therapeutic target for age-related macular degeneration | Dongcheng Liu Ziling Liu Hongxia Liao Zhe-Sheng Chen Bo Qin | 2024/2/17 | |
ABCB1-mediated chemotherapeutic drug resistance is reversed by a potent p53-MDM2 inhibitor NVP-HDM201 | Cancer Research | Harsh Patel Chaoyun Cai Zhuoxun Wu Qiuxu Teng Hanli Li | 2024/3/22 |
DNA methylation, tumor microenvironment and their effects in immunotherapy and drug resistance in thoracic tumors | Frontiers in Immunology | Limeng Qu Shirong Ding Qian Long Shaoquan Zheng Zhe-Sheng Chen | 2024/1/15 |
Recent Advances in Anti‐Atherosclerosis and Potential Therapeutic Targets for Nanomaterial‐Derived Drug Formulations | Zhicheng Xiao Yi Li Liyan Xiong Jun Liao Yijun Gao | 2023/10 | |
Gold nanoparticles and gold nanorods in the landscape of cancer therapy | Prashant Kesharwani Ruiyang Ma Liang Sang Mahak Fatima Afsana Sheikh | 2023/6/21 |
Co-Authors
